肺炎球菌结合疫苗在人道主义危机中的应用
肺炎球菌是低收入地区儿童死亡的重要原因,人道主义危机人群风险更高。肺炎球菌结合疫苗(PCV)可提供有效保护且已纳入多数国家常规免疫规划,但危机期间接种障碍多。若常规接种无法维持或PCV未纳入常规规划,大规模接种活动可作为桥接方案,但缺乏证据指导其设计。
要点
- 人道主义危机人群肺炎球菌传播和疾病严重性风险增高。
- PCV已纳入多数常规儿童免疫规划,但危机中接种受限。
- 大规模接种活动可作桥接方案,但证据不足。
核心结论
- 人道主义危机中PCV使用受证据缺乏制约,需建立证据生成路径以指导接种策略。
研究设计与样本
- 本文为综述性文章,未报告系统检索范围或样本量。
主要发现
- 肺炎球菌是低收入地区儿童死亡的重要原因,危机人群风险尤其高。
- PCV可提供有效保护,但危机中接种面临多种障碍。
- 大规模接种活动可作桥接方案,但缺乏证据指导其结构。
关键数值与推荐
- PCV可通过人道主义机制以大幅降低的价格采购。
- 证据生成路径包括原始数据收集结合数学模型,随后进行准实验评估。
临床怎么用
- 危机中若PCV常规接种无法维持或未纳入规划,可考虑大规模接种活动作为桥接。
- 接种策略需考虑年龄 targeting、剂量方案和影响持续时间。
局限性
- 危机中开展研究困难,当前缺乏指导大规模接种活动结构的证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Streptococcus pneumoniae is a common human commensal that causes a sizeable part of the overall childhood mortality in low income settings. Populations affected by humanitarian crises are at especially high risk, because a multitude of risk factors that are enhanced during crises increase pneumococcal transmission and disease severity. Pneumococcal conjugate vaccines (PCVs) provide effective protection and have been introduced into the majority of routine childhood immunisation programmes globally, though several barriers have hitherto limited their uptake during humanitarian crises. When PCV coverage cannot be sustained during crises or when PCV has not been part of routine programmes, mass vaccination campaigns offer a quick acting and programmatically feasible bridging solution until services can be restored. However, we currently face a paucity of evidence on which to base the structure of such campaigns. We believe that, now that PCV can be procured at a substantially reduced price through the Humanitarian Mechanism, this lack of information is a remaining hurdle to PCV use in humanitarian crises. Considering the difficulties in conducting research in crises, we propose an evidence generation pathway consisting of primary data collection in combination with mathematical modelling followed by quasi-experimental evaluation of a PCV intervention, which can inform on optimal vaccination strategies that consider age targeting, dosing regimens and impact duration.
引用
- van Zandvoort K, Checchi F, Diggle E, et al. Pneumococcal conjugate vaccine use during humanitarian crises. Vaccine. 2019. PMID: 31562004. doi:10.1016/j.vaccine.2019.09.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。